Atara Biotherapeutics Inc. | Key People and Executives
Issac E. Ciechanover
Chairman, President & Chief Executive Officer
William K. Heiden
Director
Roy D. Baynes
Independent Director
Carol Giltner Gallagher
Lead Independent Director
Matthew K. Fust
Independent Director
Eric L. Dobmeier
Independent Director
Beth C. Seidenberg
Independent Director
Joel S. Marcus
Independent Director
Issac E. Ciechanover
Chairman, President & Chief Executive Officer
Utpal Koppikar
Chief Financial Officer
Dietmar P. Berger
Global Head-Research & Development
Christopher M. Haqq
Chief Scientific Officer, Executive VP-R&D
Kanya Rajangam
Chief Medical Officer & Senior Vice President
Joe Newell
Chief Technical Operations Officer & Executive VP
Derrell Porter
Senior Vice President & Global Head-Commercial
Gad Soffer
Chief Strategy Officer & Executive Vice President
William K. Heiden
Director
Steve Bertram
Senior Vice President-Global Human Resources
Mina Kim
Senior Vice President & General Counsel
Mitchall G. Clark
Chief Regulatory & Quality Assurance Officer, EVP
Roy D. Baynes
Independent Director
Carol Giltner Gallagher
Lead Independent Director
Matthew K. Fust
Independent Director
Eric L. Dobmeier
Independent Director
Beth C. Seidenberg
Independent Director
Joel S. Marcus
Independent Director
| Address |
611 Gateway Boulevard
South San Francisco California 94080
United States
|
|
Employees
|
- |
| Website |
http://www.atarabio.com |
| Updated |
07/08/2019 |
| Atara Biotherapeutics, Inc. operates as a clinical stage company which focuses on developing novel therapeutics for serious unmet medical needs, with an initial focus on muscle wasting conditions and oncology. Its product candidates are biologics targeting myostatin and activin, members of the transforming growth factor-beta, protein superfamily, which play roles in the growth and maintenance of muscle and many other body tissues. The company was founded by Isaac E. |
